FIELD: medicine.
SUBSTANCE: the present innovation deals with stress-induced urinary incontinence in women due to introducing fetal stem cells. One should introduce paraurethrally into rhabdosphincter 40 mln. fetal stem myoblasts and fibroblasts obtained at 8-12 wk gestation period, cell ratio being 5-4:3-2. The innovation widens the quantity of means for treating stress-induced urinary incontinence in women and enables to exclude surgical interference.
EFFECT: higher efficiency of therapy.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING IMPERATIVE INCONTINENCE OF URINE | 2005 |
|
RU2283122C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC LOWER EXTREMITY ISCHEMIA CASES | 2005 |
|
RU2286159C1 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING DILATION CARDIOMYOPATHY | 2004 |
|
RU2268062C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF DIABETES MELLITUS OF TYPE I AND II | 2004 |
|
RU2265443C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC CARDIAC FAILURE (VARIANTS) | 2005 |
|
RU2299073C1 |
| METHODS FOR OBTAINING MUSCLE-DERIVED CELLS | 2018 |
|
RU2796929C2 |
| TISSUE FRAGMENT COMPOSITIONS FOR INCONTINENCE | 2008 |
|
RU2459627C2 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2004 |
|
RU2268061C1 |
| METHOD OF TREATMENT OF ISCHEMIC ANGIOPATHY OF LOWER EXTREMITY VESSELS | 2017 |
|
RU2649498C1 |
| BIOTRANSPLANT, METHOD FOR PRODUCTION THEREOF (VARIANTS), AND METHOD FOR ALOPECIA TREATMENT | 2004 |
|
RU2271819C1 |
